Ranibizumab (Anti-VEGFA)
Ranibizumab (Anti-VEGFA) is a recombinant humanized IgG1 monoclonal antibody fragment that inhibits (VEGF-A) and degrades angiogenesis throughout the body and in the eye also interrupts the interaction of VEGF with its receptors, and thus prevents the subsequent growth of new blood vessels.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2305 |
| Sku # | A2305-1mg*5 |
| Pricing | 1mg*5, $970.00 |